Search research articles
Contact Us
Filters
Showing results (11-20 of 157) with videos related to
Page
of 16
Sort By:
Current Opinion in Infectious Diseases
|
February 7, 2019
Influenza virus polymerase inhibitors in clinical development
Frederick G Hayden, Nahoko Shindo
The New England Journal of Medicine
|
January 25, 2013
Epidemic influenza--responding to the expected but unpredictable
Joseph Bresee, Frederick G Hayden
Expert Review of Anti-Infective Therapy
|
October 25, 2013
Therapy of H7N9 pneumonia: current perspectives
Bin Cao, Frederick G Hayden
The Journal of Infectious Diseases
|
December 14, 2006
Antiviral management of seasonal and pandemic influenza
Frederick G Hayden, Andrew T Pavia
Current Opinion in Infectious Diseases
|
July 20, 2002
Viral infections in immunocompromised patients: what's new with respiratory viruses?
Michael G Ison, Frederick G Hayden
The Journal of Infectious Diseases
|
December 4, 2012
The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1 pandemic
Fred Y Aoki, Frederick G Hayden
The Journal of Infectious Diseases
|
February 1, 2012
Fatal influenza B infections: time to reexamine influenza research priorities
Jonathan A McCullers, Frederick G Hayden
Annals of Internal Medicine
|
September 21, 2005
Influenza A (H5N1): will it be the next pandemic influenza? Are we ready?
John G Bartlett, Frederick G Hayden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2014
Editorial commentary: Host and viral factors in emergent influenza virus infections
David S Hui, Frederick G Hayden
Cold Spring Harbor Perspectives in Medicine
|
February 12, 2020
Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances
John H Beigel, Frederick G Hayden
Page
of 16
Search research articles
Search
Showing results (11-20 of 157) with videos related to
Sort By:
Page
of 16
Current Opinion in Infectious Diseases
|
February 7, 2019
Influenza virus polymerase inhibitors in clinical development
Frederick G Hayden, Nahoko Shindo
The New England Journal of Medicine
|
January 25, 2013
Epidemic influenza--responding to the expected but unpredictable
Joseph Bresee, Frederick G Hayden
Expert Review of Anti-Infective Therapy
|
October 25, 2013
Therapy of H7N9 pneumonia: current perspectives
Bin Cao, Frederick G Hayden
The Journal of Infectious Diseases
|
December 14, 2006
Antiviral management of seasonal and pandemic influenza
Frederick G Hayden, Andrew T Pavia
Current Opinion in Infectious Diseases
|
July 20, 2002
Viral infections in immunocompromised patients: what's new with respiratory viruses?
Michael G Ison, Frederick G Hayden
The Journal of Infectious Diseases
|
December 4, 2012
The beneficial effects of neuraminidase inhibitor drug therapy on severe patient outcomes during the 2009-2010 influenza A virus subtype H1N1 pandemic
Fred Y Aoki, Frederick G Hayden
The Journal of Infectious Diseases
|
February 1, 2012
Fatal influenza B infections: time to reexamine influenza research priorities
Jonathan A McCullers, Frederick G Hayden
Annals of Internal Medicine
|
September 21, 2005
Influenza A (H5N1): will it be the next pandemic influenza? Are we ready?
John G Bartlett, Frederick G Hayden
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
February 4, 2014
Editorial commentary: Host and viral factors in emergent influenza virus infections
David S Hui, Frederick G Hayden
Cold Spring Harbor Perspectives in Medicine
|
February 12, 2020
Influenza Therapeutics in Clinical Practice-Challenges and Recent Advances
John H Beigel, Frederick G Hayden
Page
of 16